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Abstract
Background—There is little data on the burden or causes of epilepsy in developing countries,
particularly in children living in sub-Saharan Africa.
Methods—We conducted two surveys to estimate the prevalence, incidence and risk factors of
epilepsy in children in a rural district of Kenya. All children born between 1991 and 1995 were
screened with a questionnaire in 2001 and 2003, and those with a positive response were then
assessed for epilepsy by a clinician. Active epilepsy was defined as two or more unprovoked
seizures with one in the last year.
Results—In the first survey, 10,218 children were identified from a census, of whom 110 had
epilepsy. The adjusted prevalence estimates of lifetime and active epilepsy were 41/1000 (95%
CI=31-51) and 11/1000 (95% CI =5-15) respectively. Overall two thirds of children had either
generalized tonic-clonic and/or secondary generalized seizures. A positive history of febrile
seizures (OR=2.75; 95% CI: 1.240-6.09) and family history of epilepsy (OR=4.12; 95% CI=
2.00-8.49) were important risk factors for active epilepsy. After the second survey, 39 children
from the same birth cohort with previously undiagnosed epilepsy were identified, thus the
incidence rate of active epilepsy is 187 per 100,000 per year (95% CI: 133-256) in children aged
6-12 years.
Conclusions—There is a considerable burden of epilepsy in older children living in this area of
rural Kenya, with a family history of seizures and a history of febrile seizures identified as risk
factors for developing epilepsy.
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Introduction
Epilepsy is the most common neurological disorder in resource-poor countries (RPCs)
(WHO, 2001). The World Bank identified epilepsy as a health priority for school age
children because of its’ high psychosocial morbidity and the potential for control using low
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cost interventions (World Bank, 1993). The World Health Organization estimates that there
are over 50 million people with epilepsy, of whom two thirds are children living in RPCs
and one fifth in sub-Saharan Africa; but there is little data on which to base this estimate
(WHO, 2001; Preux & Druet-Cabanac, 2005). Furthermore, there is even less data on
incidence and risk factors associated with epilepsy in children, on which to plan public
health interventions.
We have conducted two studies on children to determine the prevalence, incidence and risk
factors for the development of epilepsy in older children living in a rural area of sub-Saharan
Africa.
Methods
Study Setting
This study was conducted in a demarcated area in Kilifi District on the coast of Kenya. The
area was mapped in 2000 and is described elsewhere (Mung’ala-Odera et al, 2004). The
maps were used to locate each household during a census in October 2000 in which the
cohort population was defined. The population in this area has been undergoing active
surveillance since 2000.
Population
The study population consisted of children born from 01/06/1991 to 31/12/1995, who were
identified from the population database of 108,896 people, resident in the study area for at
least 6 months preceding the first survey. The population consists of the Mijikenda ethnic
group, in which the Giriama sub-group predominates.
Study Design and Methods
The first survey was conducted from June 2001 to April 2002 as part of a survey of
neurological impairment and disability (Mung’ala-Odera et al, 2006), in which parents or
guardians of all the children born from 1991 to 1995 and residing in the study area were
interviewed by fieldworkers using the ten questions questionnaire (TQQ) (Durkin et al,
1994). This questionnaire includes a single question enquiring about convulsions: “Does the
child sometimes have fits, become rigid, or lose consciousness?” This question was found to
have a sensitivity rate of 100% and specificity rate of 93% for moderate or severe lifetime
and active convulsive epilepsy (ACE), defined as convulsions occurring at least once a
month (Mung’ala-Odera et al, 2004). Children aged over 6 years were selected for this
survey due to the difficulty in differentiating between febrile and unprovoked seizures in
younger children and because by this age, most postnatal insults (particularly central
nervous system infections) will have occurred.
The second survey was conducted from September 2003 to January 2004, as part of a larger
survey of epilepsy in people of all ages (Edwards et al., in prep). In this survey, a three-
phase approach was utilized to identify individuals with convulsive epilepsy. In phase one, a
responsible respondent in each homestead was used to identify possible epilepsy cases with
the question: Is there anybody in the household who has fits or has been told that they have
fits? In phase two, individuals who were identified as positive in the first stage or their
parents/guardians had a detailed epilepsy symptoms questionnaire administered to them, to
determine those with possible ACE to be invited for detailed assessment.
Individuals identified as having epilepsy in phase two of the second survey had a detailed
assessment performed by a clinician to determine if they had seizures. Epilepsy was
diagnosed from the history. A thirty-minute electroencephalogram (EEG), with
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hyperventilation and photostimulation was performed to help classify the type of epilepsy.
Seizures were classified according to the International League against Epilepsy (ILAE,
1993). Active convulsive epilepsy was defined as more than one unprovoked convulsion,
with at least one having occurred within the preceding 12 months, since this is the criteria
for the administration of anti-epileptic drugs (AED) in Kenya (Dekker, 1994; Ministry of
Health, 1994).
All the children seen in phase 2 of the first survey (2001 to 2002) also had assessments of
cognition, vision, motor and hearing to determine impairments associated with epilepsy.
Only those with moderate or severe impairments were included in the report (Mung’ala-
Odera et al, 2006). Motor impairment was evaluated through physical examination, while
cognitive assessment involved a seven-item battery testing verbal and non-verbal skills
(Mung’ala-Odera et al, 2006). The Sonksen-Silver Acuity system was used to measure
visual acuity, hearing was measured using the Kamplex screening audiometer (Mung’ala-
Odera et al, 2006). All the assessments were performed within one week of identification. In
addition, information was also collected on the previous and current use of AEDs for
individuals with ACE. This information was used to estimate the treatment gap, defined as
the difference between the number of people with ACE and those who reported not
receiving AED in a given population at a given point in time, expressed as percentage. No
blood or saliva testing for AEDs was included in the study.
Risk factor analysis
The study on risk factors was performed in phase two of the first survey. This involved
collecting information on numerous potential risk factors for epilepsy. These risk factors
were compared to a group of 816 children within the same age range, who tested negative on
the TQQ and were randomly selected from the demographic database as part of the
neurological impairment study (Mung’ala-Odera et al, 2006). This allowed 80% power to
detect an odds ratio (OR) >3 for a variable that has a prevalence of 5% in the community
with 95% confidence. For the analysis, 25 variables were selected as potential risk factors
for epilepsy. We have categorized these into socio-demographic factors and factors
operating primarily during one of the three stages of fetal and child development: prenatal,
perinatal, and postnatal. After the initial univariate analysis, 12 variables were identified as
potential risk factors for the development of epilepsy. For the purposes of this study,
neonatal insult was defined by a history of features suggestive of birth asphyxia, neonatal
tetanus, jaundice or sepsis.
The National Ethics Committee of Kenya granted permission for the study, and consent for
the children to be involved in the study was obtained from the parents.
Data Storage and Analysis
The data was double entered into Fox-pro (version 4) and verified. For prevalence, ‘lifetime’
prevalence was used, when active and inactive epilepsy were considered together (Last et al,
1995) and prevalence of ACE was used in those who had one unprovoked convulsion
occurring within the last year. Since only a sample of those children who screened negative
were clinically evaluated, adjusted estimates of prevalence and their variance were
computed. The adjustments followed methods suggested for the epidemiological study of
rare disorders in populations (Shrout and Newman 1989). In this approach, individuals not
evaluated in the second phase of the study are also considered in the computation of both the
prevalence and its variance. For the calculation of incidence, only cases of active convulsive
epilepsy were considered. The incidence was calculated from the number of new cases
developing between the surveys, with the denominator as the number of children in whom
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information was obtained in the second survey, divided by the time period between the
surveys. .
Unadjusted univariate ORs and their corresponding 95% confidence intervals (CI) were
computed using logistic regression to evaluate associations between epilepsy and the
potential risk factors. Factors with p values less or equal to 0.25 in the univariate analysis
were used in the multiple regression model to determine the independent risk factors. Only 4
factors were retained in the final multiple logistic regression to evaluate the independent
association of each factor with epilepsy.
Results
A total of 10,218 children were screened in the first survey, 125 (1.2%) of whom were
reported to have convulsive epilepsy. The age and gender distribution of these children are
similar within the population screened. Out of those positive on the epilepsy question in the
TQQ, 113 (90%) were assessed in the second phase of the study, 12 children were not
assessed because of lack of parental consent.
Prevalence
The total number of children with confirmed epilepsy was 110 of whom 35 (31.8%) had
Active epilepsy. The unadjusted prevalences of active and lifetime epilepsy in the first
survey were 3.4 per 1000 (95% CI: 2.4 - 4.8) and 10.7 per 1000 (95% CI: 8.9 - 13.0).
Following adjustment, the prevalences were 11 (95% CI: 5.0-15.0) and 41 per 1000 (95%
CI: 31.0-51.0) (Table 1). There were no significant differences in prevalence between age
groups or gender.
Incidence of Active Convulsive Epilepsy
Over a period of 2 years and 6 months, 39 children with previously undiagnosed epilepsy
were identified in 8,326 children who could be traced and re-interviewed from the original
cohort of 10,093 who screened negative during the first survey (figure 1). This corresponds
to annual minimum incidence of 187 per 100,000 (95%CI: 133 - 256) per year. During the
second survey in 2003, thirteen of the original active cases were found to be in remission (no
seizures in the last 12 months) with 2 still taking AEDs at the time of second survey, while
six had moved out of the study area. None of the children identified with epilepsy in the first
survey had died.
Types of Seizures and age at onset
All the children had convulsive seizures, in whom about a third of children had generalized
tonic-clonic and a further third had secondary generalized seizures as their dominant type of
seizures (Table 2). Other identified seizure types were complex partial, tonic attacks and
absences. . In 24 (69%) of the active cases and 56 (75%) of the inactive cases, the onsets of
seizures were reported to be within the first two years of life.
EEG characteristics of seizures
Electroencephalograms could be performed on 80 children of whom 16 (20%) had abnormal
tracings, and six were found to have interictal epileptiform activity. Two children with
general tonic-clonic seizures had evidence of focal features on their EEG.
Risk factors
The risk factors for lifetime and active epilepsy were compared to 816 children who tested
negative on phase two evaluations. The univariate logistic regression analysis (Table 3)
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identified a history of febrile seizures, family history of seizures, birth difficulties and
neonatal insults to be significantly associated with the development of lifetime epilepsy. For
active epilepsy, a history of febrile seizures and family history of seizures were identified as
risk factors. Out of twenty-six children with epilepsy and who were reported to have been
admitted to hospital, only ten were found in the Kilifi District Hospital database. Malaria
with convulsions (n=4) and febrile convulsions (n=1) were the only central nervous system
infections identified.
After adjustment for a history of febrile seizures, other individual risk factors for lifetime
epilepsy still suggested an increased risk of epilepsy but the adjusted ORs were not
statistically significant (Table 4). For active epilepsy, after taking into account, history of
febrile seizures and family history of seizures, other independent risk factors were no longer
statistically significant (Table 4).
Associated impairments
In children with lifetime epilepsy, 34 (31%) of them had moderate or severe neurological
impairments. This included 22 (65%) with cognitive impairment, 5 (15%) with motor
impairment, 1 (3%) with vision impairment and 6 (18%) with hearing difficulties. In those
with active epilepsy, 17 (49%) of them had other neurological problems: 8 (23%) with
cognitive impairment, 2(6%) with motor impairment, 3 (9%) with hearing difficulties and 4
(11%) with speech difficulties.
Anti-epileptic drugs utilization
In 2001, only 4 (11%) children were reported to be on AEDs treatment. Two children were
taking two AEDs (one on phenobarbitone and phenytoin and the other on phenobarbitone
and carbamazepine). The other two were each on a single drug therapy, one on
phenobarbitone, while the other was using carbamazepine. Only one child (previously on
phenobarbitone) had stopped taking AEDs at the time of the second survey.
There was no difference in the nutritional status between the children with epilepsy and
those without epilepsy. In the children with ACE, significantly less attended school than
controls (14 (40%) vs 878 (60%), χ2 = 4.98, p=0.026), but there was no difference in school
attendance between those with lifetime epilepsy (55%) and those without.
Discussion
This study identifies a significant burden of epilepsy in this rural area of Africa, with around
4% of children aged 6-9 years having developed epilepsy by this age, a third of whom had
an unprovoked convulsion during the year prior to the survey. In this Kenyan population,
nearly 0.2% of children aged between 6-12 years develop epilepsy each year. A history of
febrile seizures and a family history of seizures were identified as the most important risk
factors. Most children (89%) were not receiving AED. Nearly half of the children with
active epilepsy had other impairments, in particular cognitive impairment, and were less
likely to attend school.
Prevalence
The estimate for active epilepsy in this area is higher than that established earlier in this
same community and in which a different protocol was utilized (Snow et al. 1994) and also
higher than that reported by a study done in the Rift Valley of Kenya (reported rates were
3.6/1000 when the key informants approach was used and 18.2/1000 when a randomized
cluster sampling was utilized) (Kaamugisha and Feksi 1988). Compared to studies that
utilized a protocol similar to ours, the prevalence of active epilepsy was higher than that
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measured in Bangladesh, Jamaica (Durkin et al, 1992) and South Africa (Christianson et al,
2000) (Table 5). The prevalences reported in this study are minimum estimates, since the
tools used to identify cases detected convulsive seizures and not other type of seizures e.g.
the absences. However the high prevalence of lifetime epilepsy may have been confounded
by febrile seizures, since the recall as to whether the seizures were associated with febrile
illness may be inaccurate.
Incidence of epilepsy
There are few studies that have attempted to estimate the incidence of epilepsy in Africa. A
study of a small population in Tanzania over a 10 year period estimated the incidence of
epilepsy in children aged 0-9 years to be 94/100 000 per year (Rwiza et al, 1992). A
community based study in Ethiopia, also in children aged 0-9 years, estimated the incidence
to be 68/100 000 per year (Tekle-Haimanot et al, 1997) over a period of 3.5 years. In our
study, incidence among children aged 6-9 years was 187 (95% CI: 133-256) per 100,000 per
year, considerably higher than in these studies. The other studies used different
methodologies; in particular there was reliance on the recall of seizures over a longer period
of time, which may have under reported the occurrence of seizures and use different
approaches to identify individuals with epilepsy at different time points. Furthermore it is
unclear how these studies differentiated between epilepsy and febrile seizures, since children
under six years were also included in the study. Although our study may have also been
affected by the different methods of detecting epilepsy used in the two surveys, the
incidence figure is likely to be a minimum estimate, suggesting that epilepsy is a
considerable burden in these older children, not only from the seizure perspective but also
because of additional impairments.
Seizure types and EEG findings
The high proportion of partial becoming secondary generalized seizures is similar to that
reported from other studies in Africa (Rwiza et al, 1992;Tekle-Haimanot et al, 1997;
Osuntokun, 1978), and suggests a focal aetiology. Most of these studies detected convulsive
epilepsies and may have missed partial epilepsies. In this study, the finding of moderate to
severe neurological impairments associated with epilepsy supports that there may be
identifiable causes. A relatively low percentage (20%) of children with active epilepsy had
abnormal EEG findings compared to studies in Tanzania (49%) (Matuja et al, 2001),
Ethiopia (43%) (Tekle-Haimanot et al, 1990) and Libya (62%) (Sridharan et al, 1986).
These later studies were hospital based and may have selected for more severe cases.
However the EEG findings do not support a focal etiology, although further EEGs and
neuroimaging may detect more abnormalities.
Risk factors
From the analysis of risk factors, the higher prevalence and incidence in this area could be
caused by genetic causes or febrile illnesses. We were not able to investigate the role of
antenatal or perinatal events, which have been noted in other studies (Matuja et al, 2001) as
a result of relatively small numbers and poor recall (Mung’ala-Odera & Newton, 2001). A
family history of seizures was an important risk factor identified in this study, which has
been found in earlier studies in this community (Versteeg et al, 2003) and also in studies
performed in Tanzania (Matuja et al, 2001) and Ethiopia (Tekle-Haimanot et al, 1990). This
may be related to genetic factors, which predispose individuals in a family to epilepsy,
although, environmental factors may also contribute. The finding that a seven and three-fold
increased risk of lifetime and active epilepsy respectively following febrile seizures
highlight the importance of infections as a possible cause of epilepsy. The relationship is
however complex with damage following prolonged febrile seizures, acute CNS infections
particularly malaria and illnesses provoked by other epilepsies tending to be lumped
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together in epidemiological studies. Incidence studies in this area have established rates of
190 and 202/100 000 child years for cerebral malaria (Snow et al 1993) and bacterial
meningitis respectively (Mwangi et al 2002). Infections have also been reported in other
studies of epilepsy from Africa (Annegers et al, 1979; Leviton & Cowan,1982; Ogunniyi et
al, 1987; (Matuja et al, 2001), and we have documented an association between admission
with severe falciparum malaria and the development of epilepsy (Carter et al, 2004).
Conclusion
As in many RPCs, most epilepsies in this community still remain untreated. In this
population, 89% of the active epilepsy cases had not received any medical treatment.
Probable reasons for this include lack of awareness about the availability of AEDs,
affordability and individuals’ perception about the cause of epilepsy. In this community, the
decision to seek western medical help depends upon whether the parents think the seizures
are considered as an illness, or fall within the health sphere (El Sharkawy et al, 2006).
Although children with epilepsy do not appear to be ostracized in this community (El
Sharkawy et al, 2006), those with active epilepsy are less likely to attend school possibly
due to the associated cognitive impairments, and focus group discussion have suggested that
their opportunity of marrying or obtaining jobs is impaired (El Sharkawy et al, 2006).
This study has identified a considerable burden of epilepsy in older children in this part of
rural Kenya. Genetic, neonatal insults and infections may be important causes, but further
studies are required to assess the contribution of these factors. In addition, further
examination of the treatment gap should also be performed to improve treatment of children
with epilepsy in this area.
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Figure 1. Active Epilepsy Incidence 2001-2004
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Table 2
Dominant seizure types in the Lifetime and Active Epilepsy groups of the children
diagnosed in the 2001-2002 survey
Seizure Type Lifetime Epilepsy*
n (%)
Active Epilepsy
n (%)
Generalized Tonic-Clonic 37(33.6) 16(45.7)
Secondary-Generalized 35(31.8) 8(22.9)
Complex Partial 8(7.3) 3(8.6)
Tonic Attacks 10(9.1) 2(5.7)
Generalized Absence 4(3.6) 4(11.4)
Others 14(12.7) 0(0)
Unclassifiable 2(1.8) 2(5.7)
Total 110(100) 35(100)
*
Includes both active and inactive epilepsy
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Table 4
Multiple logistic regression odds ratios for the risk factors of epilepsy
Risk factors
Lifetime epilepsy* Active epilepsy
Odds Ratios 95% CI Odds Ratios 95% CI
Family history of
seizures
1.67 0.93-2.99 2.75 1.24-6.09
Birth difficulty 1.69 0.74-3.84 1.57 0.53-4.70
History of febrile
seizures
10.75 6.77-17.09 4.12 2.00-8.49
Neonatal insults 1.23 0.88-1.72 0.92 0.52-1.63
*
Includes both active and inactive epilepsy
†Odds ratios calculated using logistic regression
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